Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population

BACKGROUND: A multitarget stool DNA test (MSDT) that showed higher sensitivity but lower specificity than a fecal immunochemical test (FIT) for hemoglobin in one recent study from the US and Canada, is increasingly used for colorectal cancer (CRC) screening, despite its ~20-fold higher costs compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Brenner, Hermann, Chen, Hongda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516775/
https://www.ncbi.nlm.nih.gov/pubmed/28761377
http://dx.doi.org/10.2147/CLEP.S136565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516775/
https://www.ncbi.nlm.nih.gov/pubmed/28761377
http://dx.doi.org/10.2147/CLEP.S136565

Ejemplares similares